Skip to content
Open access

Predictive value of systemic inflammatory indices in metabolic syndrome and non-alcoholic fatty liver disease in Iran.

Jul 2026 · Scientific Reports · 0 citations
Medicine

TL;DR

Liver fibrosis classification based on the FIB-4 index was not significantly associated with several metabolic and inflammatory variables; however, it showed significant associations with age, sex, anthropometric measures, selected inflammatory indices, and hemoglobin level.

Abstract

The prevalence of metabolic syndrome has increased significantly, and visceral obesity is closely associated with non-alcoholic fatty liver disease. This study aimed to investigate the association between inflammatory indices derived from blood cell counts and to investigate the association between inflammatory indices, metabolic syndrome, and NAFLD in Sabzevar, Iran, in 2025. This case-control study used data from a large adult cohort. A total of 1500 participants with metabolic syndrome were selected as the case group, and for each case, one control without metabolic syndrome was randomly selected from the same cohort. All participants were subsequently evaluated for the presence or absence of non-alcoholic fatty liver disease and, additionally, for liver fibrosis using the Fibrosis-4 (FIB-4) index. Data were analyzed using SPSS version 16, and a p-value < 0.05 was considered statistically significant. In this study, the mean age was 51.01 ± 8.3 years in the metabolic syndrome group and 46.9 ± 8.2 years in the healthy group. In the metabolic syndrome group, 621 participants were male and 879 were female. Overall, no significant associations were observed between metabolic syndrome and inflammatory indices, including the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammatory response index, hemoglobin level, or liver fibrosis classification based on the Fibrosis-4 (FIB-4) index. In contrast, metabolic syndrome was significantly associated with demographic factors, anthropometric measures, metabolic parameters, non-alcoholic fatty liver disease, and the monocyte-to-high-density lipoprotein cholesterol ratio. Non-alcoholic fatty liver disease showed no significant association with the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, hemoglobin level, or systemic inflammatory response index. Still, it was significantly associated with demographic characteristics, anthropometric indices, metabolic factors, the platelet-to-lymphocyte ratio, systemic immune-inflammation index. Liver fibrosis classification based on the FIB-4 index was not significantly associated with several metabolic and inflammatory variables; however, it showed significant associations with age, sex, anthropometric measures, selected inflammatory indices, and hemoglobin level. Given that imaging methods are costly and not readily accessible for all patients, the findings of this study may provide a basis for identifying more cost-effective and easily accessible approaches for the diagnosis of this disease.

Read PDF

Similar papers

Open access Sep 2026

Metabolic­-associated fatty liver disease in children with obesity: a pediatrician’s perspective

Objective — to investigate the characteristics of the development and course of metabolic-associated fatty liver disease (MAFLD) in children with obesity. Materials and methods. A total of 64 children with obesity aged 11—17 years were examined. The main group included 31 children with obesity and MAFLD; the comparison...

G. Lezhenko, O. Pashkova, K. Samoylyk · 0 citations
Open access Sep 2026

Impact of Obesity on Biochemical Parameters and the Association Between NAFLD and Type 2 Diabetes Mellitus: A Retrospective Study

Background: Non-alcoholic fatty liver disease (NAFLD), now termed metabolic dysfunction-associated steatotic liver disease (MASLD), is strongly associated with obesity, insulin resistance and type 2 diabetes mellitus (T2DM). Obesity and T2DM may contribute to hepatic steatosis, abnormal liver enzymes and atherogenic dy...

R. Rana, Moeez Zafar, Mariam Iqbal et al. · 0 citations
Open access Aug 2026

Prevalence and clinical correlates of non-alcoholic fatty liver disease in type 2 diabetes mellitus: A cross-sectional study

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent among patients with type 2 diabetes mellitus (T2DM), contributing significantly to increased morbidity and metabolic complications. Therefore, it is of interest to determine the prevalence of NAFLD in T2DM patients and compare demographic, clinical and bioch...

Syed Imran Hussain · 0 citations
Open access Aug 2026

Metabolic-associated fatty liver disease in patients undergoing hemodialysis: A cross-sectional study of prevalence and diagnostic accuracy of the triglyceride–glucose index

Metabolic dysfunction-associated fatty liver disease (MAFLD) is increasingly recognized in patients with metabolic and renal disorders; however, data in hemodialysis populations remain limited. This study assessed the prevalence of MAFLD in patients receiving maintenance HD and identified factors associated with its pr...

K. G. Abdelwahab, Ahmed E. Saleh, Ashraf Amin Abdelaziz et al. · 0 citations
Open access Aug 2026

Metabolic Risk Factors of Developing Liver Steatosis among Patients with Chronic Hepatitis B: A National Cohort from Romania.

BACKGROUND AND AIMS The coexistence of liver steatosis in patients with chronic viral hepatitis B (CHB) is growing relevant as the global epidemic of obesity and type 2 diabetes mellitus (T2DM). The aim of this study was to identify the metabolic risk factors linked to steatotic liver disease (SLD) in Romanian patients...

A. Trifan, R. Nastasa, C. Stanciu et al. · 0 citations
Open access Sep 2026

Association between atherogenic index of plasma and metabolic dysfunction-associated steatotic liver disease in Egyptian population: a case–control study

Alyrogenic index of plasma is independently and positively associated with MASLD, more degree of hepatic steatosis, insulin resistance and low adiponectin level, and using AIP alone or in combination with BMI could alarm clinicians to further investigate for presence of MASLD in individuals at outpatient clinics.

Manal Abdel-Mageed, Marium M. Shamaa, M. Labane et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.